Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Orano Med LLC
Jonsson Comprehensive Cancer Center
University of California, San Francisco
Columbia University
National Cancer Institute (NCI)
Nuvation Bio Inc.
Quadriga Biosciences, Inc.
Celgene
Celgene
SWOG Cancer Research Network
Roswell Park Cancer Institute
University of Southern California
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Arizona
SWOG Cancer Research Network
M.D. Anderson Cancer Center
University of California, San Francisco
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Envita Medical Center, Inc.
Pharmacyclics LLC.
Thallion Pharmaceuticals